Stocks and Investing Stocks and Investing
Wed, March 2, 2022
[ 12:00 AM ] - WOPRAI
Erinn Murphy Maintained (AKA) at Buy with Decreased Target to $180 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Michael Binetti Maintained (AKA) at Hold with Decreased Target to $108 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Paul Fremont Maintained (ALE) at Hold with Decreased Target to $60 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Robert Moskow Maintained (BGS) at Sell with Decreased Target to $26 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Ella Ji Maintained (BIDU) at Strong Buy with Increased Target to $228 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Stephen Bersey Upgraded (ZS) to Strong Buy and Held Target at $296 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Alex Zukin Downgraded (ZM) to Hold and Decreased Target to $100 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Jason Wittes Downgraded (ZBH) to Hold and Held Target at $130 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Jonathan Chang Maintained (ZLAB) at Buy with Decreased Target to $102 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Aaron Kessler Maintained (ZIP) at Strong Buy with Decreased Target to $41 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Ivan Feinseth Maintained (ABNB) at Strong Buy with Increased Target to $214 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Travis Steed Initiated (ABT) at Strong Buy and Held Target at $140 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Nick Giovacchini Maintained (ACHC) at Buy with Increased Target to $78 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Mohit Bansal Maintained (BMY) at Hold with Increased Target to $65 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Mark Mahaney Upgraded (BKNG) to Buy on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Ricardo Alonso Garcia Upgraded (BSAC) to Buy and Increased Target to $24 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Jason Celino Maintained (BSY) at Buy with Decreased Target to $50 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Matthew Hedberg Maintained (BSY) at Buy with Decreased Target to $55 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Christine Cho Downgraded (AM) to Sell and Decreased Target to $10 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Eric Joseph Maintained (AVIR) at Hold with Decreased Target to $8 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Jack Atkins Maintained (ATSG) at Buy with Increased Target to $40 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Bobby Griffin Maintained (AZO) at Buy on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (AZO) at Hold on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Steven Zaccone Maintained (AZO) at Strong Buy on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Christopher Horvers Maintained (AZO) at Buy on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Scot Ciccarelli Maintained (AZO) at Strong Buy on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Marc Goodman Maintained (AXSM) at Buy with Decreased Target to $50 on, Mar 2nd, 2022
Tue, March 1, 2022
[ 12:00 AM ] - WOPRAI
Colin Sebastian Maintained (BABA) at Buy with Decreased Target to $160 on, Mar 1st, 2022
[ 12:00 AM ] - WOPRAI
Douglas Miehm Maintained (AUPH) at Buy with Decreased Target to $27 on, Mar 1st, 2022
[ 12:00 AM ] - WOPRAI
Roanna Ruiz Maintained (AVIR) at Hold with Decreased Target to $9 on, Mar 1st, 2022

Roanna Ruiz Maintained (AVIR) at Hold with Decreased Target to $9 on, Mar 1st, 2022


Published on 2024-10-27 19:54:10 - WOPRAI, Roanna Ruiz
  Print publication without navigation


Roanna Ruiz of SVB Leerink, Maintained "Atea Pharmaceuticals, Inc." (AVIR) at Hold with Decreased Target from $10 to $9 on, Mar 1st, 2022.

Roanna has made no other calls on AVIR in the last 4 months.



There is 1 other peer that has a rating on AVIR. Out of the 1 peers that are also analyzing AVIR, 0 agree with Roanna's Rating of Hold.



This is the rating of the analyst that currently disagrees with Roanna

  • Matthew Harrison of "Morgan Stanley" Downgraded from Hold to Sell and Decreased Target to $7 on, Thursday, January 6th, 2022
Contributing Sources